Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
An entry point for newcomers, outlining which blockchains are simplest to learn, set up wallets, and start using.
19,955 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Investors are watching Micron Technology closely as AI-driven demand reshapes memory markets. This guide explains whe...
As the US Treasury aims to rebuild its cash balance toward 900B by June, Bitcoin traders face a potential liquidity s...
A surge in exports, a stronger currency, and deep reform push lift a frontier market into fresh highs. The world’s ho...
A flood of AI-focused stock offerings could add trillions in market value and test whether buyers can keep up with ne...
NVIDIA is expected to report a $65.7 billion Q4 revenue figure as investors weigh margin recovery against AI-driven d...
A fresh volley of missiles from Iran toward Israel marks a dangerous escalation that unsettles global markets. With a...
Synopsys is set to report its fiscal Q1 results after the bell today. Traders will watch for IP-unit performance and ...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
As XPEL gears up for 2025 earnings insights, investors need a clear view of growth drivers, margin discipline, and po...
If you’re worried about crash artificial headlines in AI stocks, a simple, cost-efficient solution can help: diversif...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...